T-group (topology)
633.22.1 Vitamin K epoxide reductase (VKOR)
Ligands and drugs
107
Member domains
16
with ligand contacts (≤ 4 Å)
15.0% of members
18
with DrugDomain annotations
16.8% of members
12
with a DrugBank compound
11.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 633.22.1 belongs to X-group 633 Bromodomain-like, which binds 10.0 ligand superclasses per 20 proteins, broader than 94% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB09270 | U10 | Ubidecarenone | 5 |
| DB14055 | SWF | (S)-Warfarin | 3 |
| DB00170 | — | Menadione | 2 |
| DB00498 | UAS | Phenindione | 2 |
| DB00266 | — | — | 1 |
| DB00682 | — | — | 1 |
| DB00946 | — | — | 1 |
| DB01022 | PQN | Phylloquinone | 1 |
| DB01418 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| U10 | UBIQUINONE-10 | 5 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 4 |
| SWF | S-WARFARIN | 3 |
| UA7 | Brodifacoum | 2 |
| UAJ | Chlorophacinone | 2 |
| PQN | PHYLLOQUINONE | 1 |
| UAS | Phenindione | 1 |
| UAV | (2R,3R)-2-hydroxy-3-methyl-2-[(2E,7S)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-2,3-dihydronaphthalene-1,4-dione | 1 |